Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 1/2020

25.04.2019 | Original Research

Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma

verfasst von: Mohaddese Maghsudlu, Ehsan Farashahi Yazd, Taghi Amiriani

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Esophageal squamous cell carcinoma (ESCC) is one of the predominant types of esophageal cancer with poor prognosis which shows high prevalence in eastern countries. Studying microRNAs that were considered for their capabilities such as tissue-specific expression and involvement in different cell features may be informative in the field of diagnostic and prognostic tumor markers. The expression levels of miR-27a and miR-24-2 have been reported to be dysregulated in various cancers and contribute in tumorigenesis and progression; thus, evaluating their expressional behavior and its association with tumor states alteration in ESCC could potentially be helpful.

Methods

The study was conducted on 30 fresh specimens including tumor and normal counterparts’ tissues of ESCC. After the extraction of total RNA, complementary DNA synthesis was performed by the use of linear specific primers. Eventually, real-time polymerase chain reaction was carried out for the measurement of microRNAs expression level.

Results

According to the obtained data, miR 27a and miR-24-2 were significantly upregulated (~2.5 fold, p < 0.05) in tumor specimens compared with their normal adjacent tissue; Moreover, upregulation of miR-27a and 24-2 showed cooperative relationship while analyzed. However, there was no correlation between clinicopathological features and microRNAs upregulation.

Conclusions

The results of this study show that miR-27a and miR-24-2 cooperatively upregulate in ESCC and suggest that these microRNAs can be introduced as a candidate for further study in the field of screening and prognostic biomarkers.
Literatur
1.
Zurück zum Zitat Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.PubMedCrossRef Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.PubMedCrossRef
2.
Zurück zum Zitat Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005;5(11):845–56.PubMedCrossRef Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005;5(11):845–56.PubMedCrossRef
3.
Zurück zum Zitat Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4(3):143–59.PubMedPubMedCentralCrossRef Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4(3):143–59.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Farazi TA, Hoell JI, Morozov P, Tuschl T. MicroRNAs in human cancer. In: MicroRNA cancer regulation. Dordrecht: Springer; 2013. pp. 1–20. Farazi TA, Hoell JI, Morozov P, Tuschl T. MicroRNAs in human cancer. In: MicroRNA cancer regulation. Dordrecht: Springer; 2013. pp. 1–20.
5.
Zurück zum Zitat Zhao B-S, Liu S-G, Wang T-Y, Ji Y-H, Qi B, Tao Y-P, et al. Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev. 2013;14(1):139–43.PubMedCrossRef Zhao B-S, Liu S-G, Wang T-Y, Ji Y-H, Qi B, Tao Y-P, et al. Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev. 2013;14(1):139–43.PubMedCrossRef
6.
Zurück zum Zitat He B, Yin B, Wang B, Xia Z, Chen C, Tang J. microRNAs in esophageal cancer (review). Mol Med Rep. 2012;6(3):459–65.PubMedCrossRef He B, Yin B, Wang B, Xia Z, Chen C, Tang J. microRNAs in esophageal cancer (review). Mol Med Rep. 2012;6(3):459–65.PubMedCrossRef
7.
Zurück zum Zitat Chhabra R, Dubey R, Saini N (2010) Cooperative and individualistic functions of the microRNAs in the miR-23a~ 27a~ 24-2 cluster and its implication in human diseases. Mol Cancer 9 (1):232.gePubMedPubMedCentralCrossRef Chhabra R, Dubey R, Saini N (2010) Cooperative and individualistic functions of the microRNAs in the miR-23a~ 27a~ 24-2 cluster and its implication in human diseases. Mol Cancer 9 (1):232.gePubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, et al. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. Oncotarget. 2015;6(7):4920–35.PubMedPubMedCentralCrossRef Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, et al. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. Oncotarget. 2015;6(7):4920–35.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Huang D, Wang H, Liu R, Li H, Ge S, Bai M, et al. miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer. J Cell Biochem. 2014;115(3):549–56.PubMedCrossRef Huang D, Wang H, Liu R, Li H, Ge S, Bai M, et al. miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer. J Cell Biochem. 2014;115(3):549–56.PubMedCrossRef
10.
Zurück zum Zitat Liu S-G, Qin X-G, Zhao B-S, Qi B, Yao WJ, Wang T-Y, et al. Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett. 2013;5(5):1639–42.PubMedPubMedCentralCrossRef Liu S-G, Qin X-G, Zhao B-S, Qi B, Yao WJ, Wang T-Y, et al. Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett. 2013;5(5):1639–42.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep. 2010;23(6):1625–33.PubMed Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep. 2010;23(6):1625–33.PubMed
12.
Zurück zum Zitat Lee S-H, Chen T-Y, Dhar SS, Gu B, Chen K, Kim YZ, et al. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness. Nucleic Acids Res. 2016;44(22):10603–18.PubMedPubMedCentralCrossRef Lee S-H, Chen T-Y, Dhar SS, Gu B, Chen K, Kim YZ, et al. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness. Nucleic Acids Res. 2016;44(22):10603–18.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Wang D, Si S, Wang Q, Luo G, Du Q, Liang Q, et al. MiR-27a promotes hemin-induced erythroid differentiation of K562 cells by targeting CDC25B. Cell Physiol Biochem. 2018;46(1):365–74.PubMedCrossRef Wang D, Si S, Wang Q, Luo G, Du Q, Liang Q, et al. MiR-27a promotes hemin-induced erythroid differentiation of K562 cells by targeting CDC25B. Cell Physiol Biochem. 2018;46(1):365–74.PubMedCrossRef
14.
Zurück zum Zitat Zhu L, Wang Z, Fan Q, Wang R, Sun. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. Oncol Rep. 2014;30(1):280–6.CrossRef Zhu L, Wang Z, Fan Q, Wang R, Sun. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. Oncol Rep. 2014;30(1):280–6.CrossRef
15.
Zurück zum Zitat Dong W, Li B, Wang Z, et al. Clinical significance of microRNA-24 expression in esophageal squamous cell carcinoma. Neoplasma. 2015;62(2):250–8.PubMedCrossRef Dong W, Li B, Wang Z, et al. Clinical significance of microRNA-24 expression in esophageal squamous cell carcinoma. Neoplasma. 2015;62(2):250–8.PubMedCrossRef
16.
Zurück zum Zitat Wang YL, Gong WG, Yuan QL. Effects of miR-27a upregulation on thyroid cancer cells migration, invasion, and angiogenesis. Genet Mol Res. 2016;4:15. Wang YL, Gong WG, Yuan QL. Effects of miR-27a upregulation on thyroid cancer cells migration, invasion, and angiogenesis. Genet Mol Res. 2016;4:15.
17.
Zurück zum Zitat Zhang S, Ma C, Pang H, Zeng F, Cheng L, Fang B, et al. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells. Biochem Biophys Res Commun. 2016;469(1):55–61.PubMedCrossRef Zhang S, Ma C, Pang H, Zeng F, Cheng L, Fang B, et al. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells. Biochem Biophys Res Commun. 2016;469(1):55–61.PubMedCrossRef
18.
Zurück zum Zitat Kerimis D, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Clin Biochem. 2017;50(6):285–92.PubMedCrossRef Kerimis D, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Clin Biochem. 2017;50(6):285–92.PubMedCrossRef
19.
Zurück zum Zitat Ba S, Xuan Y, Long Z-W, Chen H-Y, Zheng S-S. MicroRNA-27a promotes the proliferation and invasiveness of colon cancer cells by targeting SFRP1 through the Wnt/β-catenin signaling pathway. Cell Physiol Biochem. 2017;42(5):1920–33.PubMedCrossRef Ba S, Xuan Y, Long Z-W, Chen H-Y, Zheng S-S. MicroRNA-27a promotes the proliferation and invasiveness of colon cancer cells by targeting SFRP1 through the Wnt/β-catenin signaling pathway. Cell Physiol Biochem. 2017;42(5):1920–33.PubMedCrossRef
20.
Zurück zum Zitat Cui S, Liao X, Ye C, Yin X, Liu M, Hong Y, et al. ING5 suppresses breast cancer progression and is regulated by miR-24. Mol Cancer. 2017;16(1):89.PubMedPubMedCentralCrossRef Cui S, Liao X, Ye C, Yin X, Liu M, Hong Y, et al. ING5 suppresses breast cancer progression and is regulated by miR-24. Mol Cancer. 2017;16(1):89.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Ye P, Ke X, Zang X, Sun H, Dong Z, Lin J, et al. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma. Biomed Pharmacother. 2018;101:219–27.PubMedCrossRef Ye P, Ke X, Zang X, Sun H, Dong Z, Lin J, et al. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma. Biomed Pharmacother. 2018;101:219–27.PubMedCrossRef
22.
Zurück zum Zitat Lin S-C, Liu C-J, Lin J-A, Chiang W-F, Hung P-S, Chang K-W. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol. 2010;46(3):204–8.PubMedCrossRef Lin S-C, Liu C-J, Lin J-A, Chiang W-F, Hung P-S, Chang K-W. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol. 2010;46(3):204–8.PubMedCrossRef
23.
Zurück zum Zitat Lu K, Wang J, Song Y, Zhao S, Liu H, Tang D, et al. miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1. Oncol Rep. 2015;34(2):995–1002.PubMedCrossRef Lu K, Wang J, Song Y, Zhao S, Liu H, Tang D, et al. miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1. Oncol Rep. 2015;34(2):995–1002.PubMedCrossRef
24.
Zurück zum Zitat Zhang Z, Liu S, Shi R, Zhao G. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet. 2011;204(9):486–91.PubMedCrossRef Zhang Z, Liu S, Shi R, Zhao G. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet. 2011;204(9):486–91.PubMedCrossRef
25.
Zurück zum Zitat Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S, et al. C-MYC regulated miR-23a~ 24-2~ 27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem. 2013;M113:478560. Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S, et al. C-MYC regulated miR-23a~ 24-2~ 27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem. 2013;M113:478560.
26.
Zurück zum Zitat Ma Y, Yu S, Zhao W, Lu Z, Chen J. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett. 2010;298(2):150–8.PubMedCrossRef Ma Y, Yu S, Zhao W, Lu Z, Chen J. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett. 2010;298(2):150–8.PubMedCrossRef
27.
Zurück zum Zitat Zhao J, Chi J, Gao M, Zhi J, Li Y, Zheng X. Loss of PTEN expression is associated with high MicroRNA 24 level and poor prognosis in patients with tongue squamous cell carcinoma. J Oral Maxillofac Surg. 2017;75(7):1449. e1441–8.CrossRef Zhao J, Chi J, Gao M, Zhi J, Li Y, Zheng X. Loss of PTEN expression is associated with high MicroRNA 24 level and poor prognosis in patients with tongue squamous cell carcinoma. J Oral Maxillofac Surg. 2017;75(7):1449. e1441–8.CrossRef
28.
Zurück zum Zitat Du WW, Fang L, Li M, Yang X, Liang Y, Peng C, et al. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J Cell Sci. 2013;126(6):1440–53.PubMedCrossRef Du WW, Fang L, Li M, Yang X, Liang Y, Peng C, et al. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J Cell Sci. 2013;126(6):1440–53.PubMedCrossRef
29.
Zurück zum Zitat Li Y, Li J, Sun X, Chen J, Sun X, Zheng J, et al. MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor. Oncol Lett. 2016;11(6):4217–23.PubMedPubMedCentralCrossRef Li Y, Li J, Sun X, Chen J, Sun X, Zheng J, et al. MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor. Oncol Lett. 2016;11(6):4217–23.PubMedPubMedCentralCrossRef
Metadaten
Titel
Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma
verfasst von
Mohaddese Maghsudlu
Ehsan Farashahi Yazd
Taghi Amiriani
Publikationsdatum
25.04.2019
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 1/2020
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-019-00232-x

Weitere Artikel der Ausgabe 1/2020

Journal of Gastrointestinal Cancer 1/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.